Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DORZOLAMIDE vs DOSTARLIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DORZOLAMIDE vs DOSTARLIMAB: Safety Overview

Metric DORZOLAMIDE DOSTARLIMAB
Total FAERS Reports 3,814 893
Deaths Reported 8 130
Death Rate 0.2% 14.6%
Hospitalizations 144 441
Average Patient Age 65.9 yrs 65.8 yrs
% Female Patients 60.6% 91.6%
FDA Approval Date Apr 13, 2009 N/A
Manufacturer Florida Pharmaceutical Products, LLC GlaxoSmithKline LLC
Route OPHTHALMIC INTRAVENOUS
Marketing Status Discontinued N/A